Gene · 1024
Papers2,191
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,191
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Large-Scale Functional Assessment of Genes Involved in Rare Diseases with Intellectual Disabilities Unravels Unique Developmental and Behaviour Profiles in Mouse Models. | Biomedicines | 2022 | 36551904 | PubTator, text mining | PubMed |
| The era of high-quality chemical probes. | RSC Med Chem | 2022 | 36545432 | PubTator, text mining | PubMed |
| The Twofold Role of Osteogenic Small Molecules in Parkinson's Disease Therapeutics: Crosstalk of Osteogenesis and Neurogenesis. | Biomed Res Int | 2022 | 36545269 | PubTator, text mining | PubMed |
| Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta‑analysis. | Sci Rep | 2022 | 36539545 | PubTator, text mining | PubMed |
| Recent advances in machine learning methods for predicting LncRNA and disease associations. | Front Cell Infect Microbiol | 2022 | 36530425 | PubTator, text mining | PubMed |
| Capture of activated dioxygen intermediates at the copper-active site of a lytic polysaccharide monooxygenase. | Chem Sci | 2022 | 36507176 | PubTator, text mining | PubMed |
| RNA-Interference-Mediated miR-122-Based Gene Regulation in Colon Cancer, a Structural In Silico Analysis. | Int J Mol Sci | 2022 | 36499586 | PubTator, text mining | PubMed |
| Inhibition of MZF1/c-MYC Axis by Cantharidin Impairs Cell Proliferation in Glioblastoma. | Int J Mol Sci | 2022 | 36499054 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing combined with bulk RNA-sequencing analysis of peripheral blood reveals the characteristics and key immune cell genes of ulcerative colitis. | World J Clin Cases | 2022 | 36483809 | PubTator, text mining | PubMed |
| The structure, binding and function of a Notch transcription complex involving RBPJ and the epigenetic reader protein L3MBTL3. | Nucleic Acids Res | 2022 | 36477367 | PubTator, text mining | PubMed |
| Identification of m7G Methylation-Related miRNA Signature Associated with Survival and Immune Microenvironment Regulation in Uterine Corpus Endometrial Carcinoma. | Biomed Res Int | 2022 | 36467881 | PubTator, text mining | PubMed |
| Dysregulation of FBW7 in malignant lymphoproliferative disorders. | Front Oncol | 2022 | 36457505 | PubTator, text mining | PubMed |
| HOXA-AS2 may be a potential prognostic biomarker in human cancers: A meta-analysis and bioinformatics analysis. | Front Genet | 2022 | 36437956 | PubTator, text mining | PubMed |
| The Role of the Exonic lncRNA PRKDC-210 in Transcription Regulation. | Int J Mol Sci | 2022 | 36430260 | PubTator, text mining | PubMed |
| Multi-Omics Approaches in Colorectal Cancer Screening and Diagnosis, Recent Updates and Future Perspectives. | Cancers (Basel) | 2022 | 36428637 | PubTator, text mining | PubMed |
| XLID syndrome gene Med12 promotes Ig isotype switching through chromatin modification and enhancer RNA regulation. | Sci Adv | 2022 | 36427307 | PubTator, text mining | PubMed |
| Evolving DNA repair synthetic lethality targets in cancer. | Biosci Rep | 2022 | 36420962 | PubTator, text mining | PubMed |
| Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression. | Front Immunol | 2022 | 36405712 | PubTator, text mining | PubMed |
| Analysis on internal mechanism of zedoary turmeric in treatment of liver cancer based on pharmacodynamic substances and pharmacodynamic groups. | Chin Herb Med | 2022 | 36405057 | PubTator, text mining | PubMed |
| PAX3-FOXO1 coordinates enhancer architecture, eRNA transcription, and RNA polymerase pause release at select gene targets. | Mol Cell | 2022 | 36395771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1024/papers?page=19